Kristian Anderson

PRECISION HEALTH PREVIOUS SPEAKER

Kristian
Anderson
WORK
Scripps Research

Spearheaded several large international collaborations investigating the spread and evolution of severe human pathogens, including SARS-CoV-2, Zika, Ebola, West Nile, and Lassa.

Howard A. Zucker

PRECISION HEALTH PREVIOUS SPEAKER

Howard
A. Zucker
WORK
New York State

Manage New York State’s response to the COVID-19 pandemic and has worked at the helm on such critical issues as the 2018-2019 measles outbreak, vaping-related illnesses, Legionella, the Zika virus, Ebola, and medical marijuana.

Dame Sue

PRECISION HEALTH PREVIOUS SPEAKER

Professor
Dame Sue Hill
WORK
National Health Service

Chief Scientific Officer for England and the head of profession for the healthcare science workforce in the NHS, providing professional leadership and expert clinical advice across the health and care system.

Richard P. Lifton

PRECISION HEALTH PREVIOUS SPEAKER

Richard
P. Lifton
WORK
Rockefeller University

Well-known for his discovery that mutations with large effect on human blood pressure act by altering renal salt reabsorption anddiscoveries that have informed public health efforts and therapeutic strategies used worldwide to prevent heart attacks and strokes.

Mark McCarthy

PRECISION HEALTH PREVIOUS SPEAKER

Mark
McCarthy
WORK
Genentech

Leads efforts within the company to use human genetics to advance the understanding of disease and further the development of novel therapeutic and preventative approaches.

Wendy Chung

PRECISION HEALTH PREVIOUS SPEAKER

Wendy
Chung
WORK
Columbia University

Human genetics of obesity, breast cancer, pulmonary hypertension, and birth defects including congenital diaphragmatic hernia and congenital heart disease.

Robert M. Califf

PRECISION HEALTH PREVIOUS SPEAKER

Robert
M. Califf
WORK
Duke University & Stanford University

Nationally and internationally recognized leader in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research

Eric D. Green

PRECISION HEALTH PREVIOUS SPEAKER

Eric
D. Green
WORK
National Human Genome Research Institute

Human Genome Project and groundbreaking work on mapping, sequencing, and characterizing mammalian genomes

Geoffrey S. Ginsburg

PRECISION HEALTH PREVIOUS SPEAKER

Geoffrey
S. Ginsburg
WORK
National Institutes of Health

Translating genomic information into medical practice and the integration of precision medicine into healthcare

previous arrow
next arrow

2024 Speakers

Kathleen Barnes

Kathleen’s career spans >30 years focused on genomic medicine and precision-driven health equity. She completed her BSN at the Medical College of Virginia, her PhD in Biomedical Anthropology at the University of Florida, and a postdoctoral fellowship in Immunogenetics at Johns Hopkins University. She has built research and clinical programs and has led interdisciplinary teams integrating biomedical informatics, multi-omics platforms, translational research and global health at Johns Hopkins University (1993-2015) and the University of Colorado (2015-present), where she founded the Colorado Center for Personalized Medicine,and was SVP of Population Genomics Health at Tempus Labs (2021-2023). Most recently she joined Oxford Nanopore Technologies to stand up a new program in Population Health and Precision Medicine.

Nancy J. Cox

Dr. Nancy Cox is a quantitative human geneticist and the Mary Phillips Edmonds Gray Professor of Genetics at Vanderbilt University Medical Center. Dr. Cox’s research interests focus on large-scale integration of genomics with methods for the analysis of genome data on translational phenotypes and common diseases, such as Alzheimer’s disease. Dr. Cox is a member of the Internal Advisory Committee and an investigator in the Vanderbilt Alzheimer’s Disease Research Center.

Dr. Cox completed her doctoral degree in human genetics at Yale University, a postdoctoral fellowship in psychiatric genetics at Washington University, and a postdoctoral fellowship in the genetics of diabetes at University of Pennsylvania. Dr. Cox joined the Vanderbilt faculty in 2015.

Dr. Kyle Farh

Dr. Kyle Farh is Vice President at Illumina’s Artificial Intelligence (AI) Lab for Genome Interpretation, where he deciphers the clinical impact of genetic variants in rare and common diseases. Towards this goal, Kyle leads a multidisciplinary research team of deep learning scientists, statistical geneticists, and molecular biologists. Prior to joining Illumina, Kyle was an attending physician at Boston Children’s Hospital. Kyle completed his postdoc fellowship in Medical and Population Genetics at the Broad Institute, and received his PhD in Molecular Biology at MIT, MD at Harvard Medical School, and BS in Computer Science from Rice University.

Melissa Haendel

University of Colorado

Melissa Haendel is the Director of Precision Health & Translational Informatics and the Sarah Graham Kenan Distinguished Professor in the Department of Genetics at The University of North Carolina at Chapel Hill and co-founder of the Monarch Initiative and the National Covid Cohort Collaborative. Her background is molecular genetics and developmental biology as well as translational informatics, with a focus over the past decade on open science and semantic engineering. (more…)

Eimear Kenny

Eimear Kenny, PhD, is the Founding Director of the Institute for Genomic Health, building resources for integrating genomic information and AI in routine clinical care, and supporting the sequencing and return of results to a diverse patients in the Mount Sinai Health System. She also the Founding Director of the Center for Translational Genomics and a Professor of Medicine and Genetics, at the Icahn School of Medicine at Mount Sinai, working on computational and translational genomic research.She is Principal Investigator in many large NIH-funded international consortium focused on computational genomics and genomic medicine, including eMERGE, PRIMED, CSER, GSP, TOPMed, PAGE, and HPRC. (more…)

Josh Peterson

Vanderbilt University Medical Center

Josh Peterson, MD, MPH serves as a Professor of Biomedical Informatics and Medicine in the School of Medicine at Vanderbilt University Medical Center, the Director of the Center for Precision Medicine, and the Vice-President for Personalized Medicine.

Dr. Peterson is an internationally recognized researcher and educator in Biomedical Informatics and maintains an Internal Medicine practice at VUMC.  He has authored more than 120 peer-reviewed publications, abstracts, reviews, and book chapters.  Dr. Peterson’s research interests are in precision medicine with a focus on clinical decision support to improve drug safety and efficacy, and the translation of genomic technologies to routine clinical care.

(more…)

Jennifer Posey

Baylor College of Medicine

As a physician-scientist and a medical and human geneticist, my ultimate goal is to be able to translate our understanding of the relationship between an individual’s genotype and phenotype into actionable and treatable information in the clinic. The first step toward this goal is the elucidation of the complex relationships between genotypes and human disease phenotypes.

Aaron Quinlan

Aaron Quinlan is an Endowed Professor of Human Genetics and Biomedical Informatics at the University of Utah. His laboratory has developed numerous foundational, open-source software tools that facilitate discovery in genomics for thousands of researchers worldwide. His research program explores the causes and consequences of germline and somatic mutations on development, fertility, and health. By applying computational advances to massive genomic datasets, his laboratory has charted maps of genetic constraint in genes, observed surprising variability in the rate at which germline mutations arise and accumulate in sperm, and has unveiled potential connections between germline mutations and health. More information can be found at www.quinlanlab.org.

Elise Robinson

Massachusetts General Hospital and Broad Institute

Elise Robinson is a faculty member in the Center for Genomic Medicine and Department of Psychiatry at Massachusetts General Hospital and an institute member of the Broad Institute of MIT and Harvard. She is also an affiliated faculty member with the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and the Analytic and Translational Genetics Unit at Massachusetts General Hospital.

Robinson’s research focuses on the genetic influences on behavior and cognition. She is interested in using genetic data to understand the biology of neurodevelopmental variation, and to study differences within and between neuropsychiatric disorders. She co-chairs the Autism Working Group of the Psychiatric Genomics Consortium, the NeuroDevelopmental Variability Initiative (NDV) at the Broad Institute, and the NeuroDev project. (more…)

Jordan Smoller

Massachusetts General Hospital

Jordan Smoller, MD, ScD is a psychiatrist, epidemiologist and geneticist whose research focus has been understanding the genetic and environmental determinants of psychiatric disorders across the lifespan and using big data to advance precision mental health including improved methods to reduce risk and enhance resilience.

Dr. Smoller is the Jerrold F. Rosenbaum Endowed Chair in Psychiatry,  professor of Psychiatry at Harvard Medical School and professor in the Department of Epidemiology at the Harvard School of Public Health in Boston.  He is director of the Psychiatric and Neurodevelopmental Genetics Unit in the MGH Center for Genomic Medicine and director of the Center for Precision Psychiatry in the MGH Department of Psychiatry.  (more…)

Joris R. Vermeesch

Joris R. Vermeesch, Ph.D. Ir, is a professor of Molecular Cytogenetics and genome research, staff member of the center for human genetics Leuven, and scientific director of the genomic core facility of the KU Leuven. He is president elect of PGDIS (International Society of preimplantation genetic Diagnosis) and board member of ISPD (International Society of Prenatal Diagnosis).

The laboratory develops and translates novel genomics methods in preimplantation, prenatal and postnatal diagnosis and more recently, cancer screening. We pioneered array CGH, single cell arrays, massive parallel short and long read sequencing and cell free DNA analysis.  Those developments have led to new approaches for rare disease testing, structural PGT, NIPS and cancer detection. He is leading the Belgian Genome Biobanking project and participating in the 1+MG. Prof. Vermeesch has published over 400 publications with a WOS H-index 64 and GS H-index 84.